US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Mangoceuticals Inc (MGRX)
Mangoceuticals Inc (MGRX) ニュース

MGRX

Mangoceuticals (MGRX)

Mangoceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MGRX

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/27	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGRX	Mangoceuticals Inc
2024/12/20	07 : 33	GlobeNewswire Inc.	Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent	NASDAQ:MGRX	Mangoceuticals Inc
2024/12/20	07 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGRX	Mangoceuticals Inc
2024/12/07	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGRX	Mangoceuticals Inc
2024/12/04	21 : 00	GlobeNewswire Inc.	Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split	NASDAQ:MGRX	Mangoceuticals Inc
2024/11/15	06 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MGRX	Mangoceuticals Inc
2024/11/13	07 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGRX	Mangoceuticals Inc
2024/10/31	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGRX	Mangoceuticals Inc
2024/10/31	21 : 00	GlobeNewswire Inc.	Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:MGRX	Mangoceuticals Inc
2024/10/26	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGRX	Mangoceuticals Inc
2024/10/22	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGRX	Mangoceuticals Inc
2024/10/22	21 : 00	GlobeNewswire Inc.	MangoRx Announces Formation of Strategy and Alternatives Committee	NASDAQ:MGRX	Mangoceuticals Inc
2024/10/22	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGRX	Mangoceuticals Inc
2024/10/22	06 : 10	GlobeNewswire Inc.	MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly	NASDAQ:MGRX	Mangoceuticals Inc
2024/10/12	06 : 15	GlobeNewswire Inc.	MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN	NASDAQ:MGRX	Mangoceuticals Inc
2024/10/03	21 : 30	GlobeNewswire Inc.	MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions	NASDAQ:MGRX	Mangoceuticals Inc
2024/10/02	02 : 05	AllPennyStocks.com	Healthcare Shares Rise Following Product Availability Announcement	NASDAQ:MGRX	Mangoceuticals Inc
2024/10/01	20 : 30	GlobeNewswire Inc.	MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment	NASDAQ:MGRX	Mangoceuticals Inc
2024/08/15	22 : 25	GlobeNewswire Inc.	MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024	NASDAQ:MGRX	Mangoceuticals Inc
2024/08/14	05 : 00	GlobeNewswire Inc.	MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent	NASDAQ:MGRX	Mangoceuticals Inc
2024/08/09	21 : 15	GlobeNewswire Inc.	MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide	NASDAQ:MGRX	Mangoceuticals Inc
2024/07/24	21 : 15	GlobeNewswire Inc.	MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology	NASDAQ:MGRX	Mangoceuticals Inc
2024/07/19	05 : 05	GlobeNewswire Inc.	Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access	NASDAQ:MGRX	Mangoceuticals Inc
2024/07/16	21 : 20	GlobeNewswire Inc.	MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts	NASDAQ:MGRX	Mangoceuticals Inc
2024/07/13	02 : 30	GlobeNewswire Inc.	MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department	NASDAQ:MGRX	Mangoceuticals Inc
2024/07/11	21 : 15	GlobeNewswire Inc.	MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/19	03 : 57	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/11	02 : 28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/06	21 : 30	GlobeNewswire Inc.	MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/06	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGRX	Mangoceuticals Inc

Showing the most relevant articles for your search:NASDAQ:MGRX

1 2 3 次へ >>

American Express

US Dollar vs Euro

Verizon Communications

Invesco QQQ Trust Series 1

Health Care Select Sector

Deutsche Telekom (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約